OUR EXPERIENCES WITH CYTOSTATIC PERFUSIONS OF THE EXTREMITIES IN THE TREATMENT OF MALIGNANT TUMORS.
D000818:Animals; D001859:Bone Neoplasms; D010478:Chemotherapy, Cancer, Regional Perfusion; D003520:Cyclophosphamide; D004285:Dogs; D004358:Drug Therapy; D005266:Femoral Neoplasms; D005354:Fibrosarcoma; D006354:Heart, Artificial; D008466:Mechlorethamine; D008545:Melanoma; D009369:Neoplasms; D012516:Osteosarcoma; D011379:Prognosis; D012509:Sarcoma; D013852:Thiotepa
D008466:Mechlorethamine; D003520:Cyclophosphamide; D013852:Thiotepa
BONE NEOPLASMS; CYCLOPHOSPHAMIDE; DOGS; DRUG THERAPY; FEMORAL NEOPLASMS; FIBROSARCOMA; HEART, MECHANICAL; ISOLATION PERFUSION; MECHLORETHAMINE; MELANOMA; PROGNOSIS; SARCOMA; SARCOMA, OSTEOGENIC; THIO-TEPA